131 related articles for article (PubMed ID: 7634398)
1. Inhibition of ligand-induced activation of epidermal growth factor receptor tyrosine phosphorylation by curcumin.
Korutla L; Cheung JY; Mendelsohn J; Kumar R
Carcinogenesis; 1995 Aug; 16(8):1741-5. PubMed ID: 7634398
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effect of curcumin on epidermal growth factor receptor kinase activity in A431 cells.
Korutla L; Kumar R
Biochim Biophys Acta; 1994 Dec; 1224(3):597-600. PubMed ID: 7803521
[TBL] [Abstract][Full Text] [Related]
3. Expression of human tyrosine kinase-negative epidermal growth factor receptor amplifies signaling through endogenous murine epidermal growth factor receptor.
Hack N; Sue-A-Quan A; Mills GB; Skorecki KL
J Biol Chem; 1993 Dec; 268(35):26441-6. PubMed ID: 8253771
[TBL] [Abstract][Full Text] [Related]
4. Transmembrane signalling at epidermal growth factor receptors overexpressed in NIH 3T3 cells. Phosphoinositide hydrolysis, cytosolic Ca2+ increase and alkalinization correlate with epidermal-growth-factor-induced cell proliferation.
Pandiella A; Beguinot L; Velu TJ; Meldolesi J
Biochem J; 1988 Aug; 254(1):223-8. PubMed ID: 2845945
[TBL] [Abstract][Full Text] [Related]
5. Epidermal growth factor stimulates urokinase-type plasminogen activator expression in human gingival fibroblasts. Possible modulation by genistein and curcumin.
Smith PC; Santibañez JF; Morales JP; Martinez J
J Periodontal Res; 2004 Dec; 39(6):380-7. PubMed ID: 15491342
[TBL] [Abstract][Full Text] [Related]
6. Anti-oncogenic activity of signalling-defective epidermal growth factor receptor mutants.
Redemann N; Holzmann B; von Rüden T; Wagner EF; Schlessinger J; Ullrich A
Mol Cell Biol; 1992 Feb; 12(2):491-8. PubMed ID: 1346334
[TBL] [Abstract][Full Text] [Related]
7. Epidermal growth factor induces tyrosine phosphorylation of epidermal growth factor receptors not occupied with ligand in intact A431 cells.
Sorokin AB; Reshetnikova GF; Kudryavtseva NV; Nikolsky NN
FEBS Lett; 1990 Jul; 268(1):121-4. PubMed ID: 1696547
[TBL] [Abstract][Full Text] [Related]
8. A potent protein-tyrosine kinase inhibitor which selectively blocks proliferation of epidermal growth factor receptor-expressing tumor cells in vitro and in vivo.
Lydon NB; Mett H; Mueller M; Becker M; Cozens RM; Stover D; Daniels D; Traxler P; Buchdunger E
Int J Cancer; 1998 Mar; 76(1):154-63. PubMed ID: 9533776
[TBL] [Abstract][Full Text] [Related]
9. Conversion of epidermal growth factor (EGF) into a stimulatory ligand for A431-cell growth by herbimycin A by decreasing the level of expression of EGF receptor.
Murakami Y; Fukazawa H; Mizuno S; Uehara Y
Biochem J; 1994 Jul; 301 ( Pt 1)(Pt 1):57-62. PubMed ID: 8037691
[TBL] [Abstract][Full Text] [Related]
10. Endothelium-derived nitric oxide (NO) activates the NO-epidermal growth factor receptor-mediated signaling pathway in bradykinin-stimulated angiogenesis.
Moraes MS; Costa PE; Batista WL; Paschoalin T; Curcio MF; Borges RE; Taha MO; Fonseca FV; Stern A; Monteiro HP
Arch Biochem Biophys; 2014 Sep; 558():14-27. PubMed ID: 24960080
[TBL] [Abstract][Full Text] [Related]
11. Two independent mechanisms for escaping epidermal growth factor-mediated growth inhibition in epidermal growth factor receptor-hyperproducing human tumor cells.
Hirai M; Gamou S; Minoshima S; Shimizu N
J Cell Biol; 1988 Aug; 107(2):791-9. PubMed ID: 2458359
[TBL] [Abstract][Full Text] [Related]
12. Epidermal growth factor-specific protein tyrosine phosphorylation in preimplantation embryo development.
Paria BC; Tsukamura H; Dey SK
Biol Reprod; 1991 Nov; 45(5):711-8. PubMed ID: 1721842
[TBL] [Abstract][Full Text] [Related]
13. Transactivation of the epidermal growth factor receptor in endothelin-1-induced mitogenic signaling in human ovarian carcinoma cells.
Vacca F; Bagnato A; Catt KJ; Tecce R
Cancer Res; 2000 Sep; 60(18):5310-7. PubMed ID: 11016663
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of cell growth: effects of the tyrosine kinase inhibitor CGP 53716.
Major TC; Keiser JA
J Pharmacol Exp Ther; 1997 Oct; 283(1):402-10. PubMed ID: 9336349
[TBL] [Abstract][Full Text] [Related]
15. Early events in the antiproliferative action of tumor necrosis factor are similar to the early events in epidermal growth factor growth stimulation.
Donato NJ; Ince C; Rosenblum MG; Gallick GE
J Cell Biochem; 1989 Nov; 41(3):139-57. PubMed ID: 2482293
[TBL] [Abstract][Full Text] [Related]
16. Blocking of EGF-dependent cell proliferation by EGF receptor kinase inhibitors.
Yaish P; Gazit A; Gilon C; Levitzki A
Science; 1988 Nov; 242(4880):933-5. PubMed ID: 3263702
[TBL] [Abstract][Full Text] [Related]
17. Epiregulin stimulates proliferation of rabbit gastric cells in primary culture through autophosphorylation of the epidermal growth factor receptor.
Sasaki E; Arakawa T; Fujiwara Y; Kawada N; Fukuda T; Higuchi K; Komurasaki T; Kobayashi K
Eur J Pharmacol; 1997 Nov; 338(3):253-8. PubMed ID: 9424019
[TBL] [Abstract][Full Text] [Related]
18. Genistein and erbstatin inhibition of normal mammary epithelial cell proliferation is associated with EGF-receptor down-regulation.
McIntyre BS; Sylvester PW
Cell Prolif; 1998 Feb; 31(1):35-46. PubMed ID: 9666817
[TBL] [Abstract][Full Text] [Related]
19. Identification of epidermal growth factor receptor and c-erbB2 pathway inhibitors by correlation with gene expression patterns.
Wosikowski K; Schuurhuis D; Johnson K; Paull KD; Myers TG; Weinstein JN; Bates SE
J Natl Cancer Inst; 1997 Oct; 89(20):1505-15. PubMed ID: 9337347
[TBL] [Abstract][Full Text] [Related]
20. Structural aspects of the epidermal growth factor receptor required for transmodulation of erbB-2/neu.
Worthylake R; Wiley HS
J Biol Chem; 1997 Mar; 272(13):8594-601. PubMed ID: 9079690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
